Modulation of cellular apoptosis with apoptotic protease-activating factor 1 (Apaf-1) inhibitors

Area of Science:

• Molecular Biology
• Cell Death Research
• Biochemistry

Background:

• Programmed cell death (apoptosis) is crucial in biology, with aberrant apoptosis linked to diseases like cancer.
• The intrinsic mitochondrial pathway initiates apoptosis via the apoptosome, a protein complex centered on Apaf-1.
• Targeting the apoptosome presents a potential therapeutic strategy for controlling cell death.

Purpose of the Study:

• To discover and develop novel inhibitors of the apoptosome.
• To investigate the therapeutic potential of these inhibitors in cellular models of apoptosis and hypoxic injury.

Main Methods:

• Identification of molecules binding to Apaf-1, a core apoptosome component.
• Chemical modification of lead compounds to improve cellular penetration.
• Assessment of inhibitor efficacy in cellular apoptosis models and in neonatal rat cardiomyocytes subjected to hypoxia.

Main Results:

• Discovery of first-in-class apoptosome inhibitors targeting Apaf-1.
• Enhanced compounds demonstrated improved cellular uptake and efficacy.
• Inhibitors successfully decreased cell death in both general apoptosis models and under hypoxic stress in cardiomyocytes.

Conclusions:

• Apaf-1-targeting molecules represent a promising new class of apoptosome inhibitors.
• Optimized inhibitors show potential for treating conditions associated with excessive apoptosis, including malignancies and ischemic injury.
• Further development could lead to novel therapeutics for apoptosis-related diseases.